 |
Articles: Drug/Product Approvals |
Prior Articles
Orally Disintegrating Tablets: The Effect of Recent FDA Guidance on ODT Technologies and Applications
Pharmaceutical Technology, 10/14/09
Free full text
Novartis enters into agreement for exclusive US and Canadian rights to Fanapt(TM), an FDA-approved oral therapy for schizophrenia
Novartis, 10/13/09
Free full text
APP Pharmaceuticals Receives Approval for Sumatriptan Succinate Injection, USP
American Pharmaceutical Partners, 10/09/09
Free full text
Licensed Vaccines for Rotavirus Prevention in the US: A Review
Journal of Pharmacy Technology, 10/08/09 Safer colchicine dosing regimen approved
American Pharmacists Association, 10/08/09
Free full text
Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex Biliary RX Covered Stents
Boston Scientific, 10/07/09
Free full text
Fda approves new indication for mirena to treat heavy menstrual bleeding in iud users
Bayer HealthCare Pharmaceuticals, 10/07/09
Free full text
Novartis completes shipment of US supply of Fluvirin seasonal influenza vaccine
Novartis, 10/07/09
Free full text
Genzyme Receives FDA Complete Response Letter for Clolar
Genzyme, 10/07/09
Free full text
CryoLife Receives Humanitarian Use Device Designation for SynerGraft(R) Processed Human Aortic Heart Valves
Cryolife, 10/07/09
Free full text
Cell Therapeutics Applies for European Orphan Drug Designation for Pixantrone in Aggressive Non-Hodgkins Lymphoma
Cell Therapeutics, 10/07/09
Free full text
UCB"s Cimzia, the Only Pegylated Anti-tnf, Approved in Europe
Enzon Pharmaceuticals, 10/07/09
Free full text
GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT
GlaxoSmithKline, 10/06/09
Free full text
PEGINTRON Receives a Recommendation for Approval from FDA Advisory Committee for a New Application in Melanoma
Enzon Pharmaceuticals, 10/06/09
Free full text
Allos Therapeutics Announces U.S. Availability of FOLOTYN(TM) (pralatrexate injection) for Relapsed or Refractory Peripheral T-Cell Lymphoma
Allos Therapeutics, 10/06/09
Free full text
Sandoz launches somatropin, the first-ever Japanese biosimilar, increasing access to key medicines in second largest global market
Novartis, 10/06/09
Free full text
ONGLYZA (saxagliptin) Receives Marketing Authorisation In Europe For The Treatment Of Type 2 Diabetes
Bristol Myers-Squibb Company, 10/06/09
Free full text
Avodart (dutasteride) Regulatory Update
GlaxoSmithKline, 10/02/09
Free full text
APP Pharmaceutical Supports New USP Standards for Unfractionated Heparin
American Pharmaceutical Partners, 10/02/09
Free full text
InVivo and CEVEC pharmaceuticals sign license agreement regarding the use of human CAP-T™ Technology for production of recombinant proteins
b3c newswire, 10/02/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
